Immunohistochemistry as an accurate tool for the assessment of BRAF V600E and TP53 mutations in primary and metastatic melanoma-Reference-Cited by-同舟云学术

Immunohistochemistry as an accurate tool for the assessment of BRAF V600E and TP53 mutations in primary and metastatic melanoma

Published:2021-11-01 Issue:6 Volume:15 Page:
ISSN:2049-9450
Container-title:Molecular and Clinical Oncology
language:
Short-container-title:Mol Clin Oncol

Author:

Rusu Stefan¹,Verocq Camille¹,Trepant Anne¹,Maris Calliope¹,De Nève Nancy¹,Blanchard Oriane¹,Van Campenhout Claude¹,De Clercq Sarah¹,Rorive Sandrine¹,Cotoi Ovidiu²,Decaestecker Christine³,Salmon Isabelle¹,D'haene Nicky¹

Affiliation:

1. Department of Pathology, Erasme University Hospital, Université Libre de Bruxelles, B‑1070 Brussels, Belgium

2. Department of Pathology, Clinical County Hospital of Targu Mures, University of Medicine, Pharmacy, Science and Technology ‘George Emil Palade’ of Targu Mures, Targu Mures, RO‑540139 Mures County, Romania

3. DIAPath‑Center for Microscopy and Molecular Imaging, Université Libre de Bruxelles, B‑6041 Gosselies, Belgium

Publisher

Spandidos Publications

Subject

Cancer Research,Oncology

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluation of P53 immunostaining in patients with cutaneous melanoma;Biomedical Reports;2023-11-22

2. The Pathology according to p53 Pathway;Pathobiology;2023-11-14

3. A case of developing odontoma of the mandible with suspected BRAF p.V600E mutation;Journal of Oral and Maxillofacial Surgery, Medicine, and Pathology;2023-09

4. Usefulness of BRAF VE1 immunohistochemistry in non–small cell lung cancers: a multi-institutional study by 15 pathologists in Korea;Journal of Pathology and Translational Medicine;2022-11-15